Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-07-22HRMY3Stephen Mollichella Form 4: Equity Awards for Harmony Biosciences CFO
This Form 4 filing reports equity awards for Stephen M. Mollichella, Interim Principal Financial Officer of Harmony Biosciences Holdings, Inc. The filing discloses multiple stock option grants and restricted stock units awarded to Mollichella. The stock options include grants for 12,172 shares at $37.46 exercise price ...
Mid CapBiotechnology
2026-07-22JSPR3Power of Attorney for Matthew E. RosMEDIUM
This filing details a Power of Attorney granted by Matthew E. Ros, Chief Operating Officer of Jasper Therapeutics, Inc., to Herb Cross and Jeetinder Singh Mahal. The attorneys-in-fact are authorized to act on Mr. Ros's behalf regarding SEC filings, including Forms 3, 4, 5, Schedules 13D and 13G, and Forms 144. They are...
Nano CapBiotechnology
2026-07-22JSPR3Power of Attorney for Jasper Therapeutics, Inc. SEC FilingsMEDIUM
This filing is an Exhibit 24, a Power of Attorney granted by Wenru Song, EVP, Head of R&D at Jasper Therapeutics, Inc., to Herb Cross and Jeetinder Singh Mahal. The power of attorney authorizes the attorneys-in-fact to act on behalf of Wenru Song regarding SEC filings, including executing and filing Forms 3, 4, 5, Sche...
Nano CapBiotechnology
2026-07-22Harmony Biosciences Holdings, Inc.3Stephen Mollichella Form 4: Equity Awards for Harmony Biosciences CFODuplicate
This Form 4 filing reports equity awards for Stephen M. Mollichella, Interim Principal Financial Officer of Harmony Biosciences Holdings, Inc. The filing discloses multiple stock option grants and restricted stock units awarded to Mollichella. The stock options include grants for 12,172 shares at $37.46 exercise price ...
Mid CapBiotechnology